Cargando…
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
A risk model for febrile neutropenia (FN) after conventional cytotoxic chemotherapy, based on early (day 5) lymphopenia and the dose of chemotherapy, has been described. A risk index based on parameters available at day 1 would be easier in daily practice. The objectives of this work were (1) to inv...
Autores principales: | Ray-Coquard, I, Borg, C, Bachelot, Th, Sebban, C, Philip, I, Clapisson, G, Le Cesne, A, Biron, P, Chauvin, F, Blay, J Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377052/ https://www.ncbi.nlm.nih.gov/pubmed/12610500 http://dx.doi.org/10.1038/sj.bjc.6600724 |
Ejemplares similares
-
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas
por: Ray-Coquard, I, et al.
Publicado: (2001) -
Incidence and Impact of Baseline Electrolyte Abnormalities in Patients Admitted with Chemotherapy Induced Febrile Neutropenia
por: Shaikh, Asim Jamal, et al.
Publicado: (2011) -
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients
por: Manuel, Manuarii, et al.
Publicado: (2012) -
Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009) -
Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)